InSysBio to take part in ACoP 2026

events
Conference
September 9, 2026

InSysBio announces its participation in 2026 American Conference on Pharmacometrics (ACoP 2026) which is to be held from October 11-14, 2026 at the Gaylord National Resort & Convention Center, Oxon Hill, Maryland, USA. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #11 and 6 posters, namely:

Monday, October 12, 2026 7:00 AM - 5:00 PM EDT

  • (M-088) "Evaluating Combination Dosing Regimens of the Anti-BCMA Antibody-Drug Conjugate Belantamab Mafodotin and Monoclonal Antibody Belantamab in Relapsed or Refractory Multiple Myeloma Using QSP modeling" by Jingqi Q. X. Gong1, Galina Lebedeva2, Alexandra Diakonova2, Geraldine Ferron-Brady1, Oleg Demin2, John D. Clements1

Affiliations: (1) GSK, Upper Providence, PA, USA, (2) InSysBio

  • (M-089) "QSP Model of PSMAxCD3 T-cell Engagers Generates Cytokine-based CRS Risk and Efficacy-related Biomarker Predictions to Optimize Clinical Dosing Strategies" by Jingqi Q. X. Gong1, Tatiana Karelina2, Dmitry Shchelokov2, Polina Maliukova2, Olga Ivanova2, Maria Myshkina2, Oleg Demin Jr2, John Clements1, Stefan Zajic1, Murad Melhem3

Affiliations: (1) GSK, Collegeville, PA, USA, (2) InSysBio, (3) GSK, Waltham, MA, USA

Tuesday, October 13, 2026 7:00 AM - 5:00 PM EDT

  • (T-038) "SBML-based genome-scale QSP modelling of asthma integrating CYTOCON DB, EHMN2026 with Neural ODEs" by Igor Goryanin1,3, Oleg Demin2, Irina Goryanin3

Affiliations: (1) University of Edinburgh, (2) InSysBio, (3) IQANOVA LTD

  • (T-048) "AI-assisted SBML-based QSP modelling of CAR-T therapy: automated model evolution, calibration, and combination therapy evaluation" by Igor Goryanin1,3, Oleg Demin2, Irina Goryanin3

Affiliations: (1) University of Edinburgh, (2) InSysBio, (3) IQANOVA LTD

  • (T-113) "Simplified tau pathology model for preclinical efficacy of PROTAC to investigate translation from in vitro protein degradation to in vivo efficacy" by Tatiana Karelina, Marina Morozova

Wednesday, October 14, 2026 7:00 AM - 1:30 PM EDT

  • (W-093) "Context-of-Use–Driven Validation of Machine Learning Surrogate Models for Accelerating Virtual Patient Workflows in a QSP Model of Erythropoiesis" by Anna Viktorenko1, Alexander Stepanov1, Igor Goryanin2, Oleg Demin1

Affiliations: (1) InSysBio, (2) University of Edinburgh

Check out our posters and Booth #11 at ACoP 2026!

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio's cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

March 2017
MoTuWeThFrSaSu
  
1
2
3
4
5
6
7
8
9
1. 09 Mar 2017 14:10 ISBM Enclosed Conference was held 20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.
10
11
12
13
14
15
1. 15 Mar 2017 11:49 Institute for Systems Biology participates in American Society for Clinical Pharmacology and Therapeutics 2017 Meeting Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT).
16
17
18
19
20
21
22
23
24
25
26
27
28
1. 28 Mar 2017 17:56 Not all therapies are effective: Institute for Systems Biology Moscow to present the results of the Alzheimer’s disease Systems Pharmacology Modeling Moscow, Russia – March 28, 2017. On the 1st April, Tatyana Karelina, ISBM leading specialist in neurodegenerative field, will present a poster entitled "Amyloid toxicity and different mechanisms of action for amyloid-targeted treatments studied by quantitative systems pharmacology model" at the 13th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders to be held on March 29 - April 2, Vienna, Austria.
29
30
31
  
Upcoming Events
11.10
InSysBio to take part in ACoP 2026
Tags
Latest News
10.06
16th InSysBio’s Annual Internal Scientific Meeting
28.01
InSysBio to announce a new collaborative project with BeOne Medicines
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"